抗血友病用薬の世界市場動向・分析2018-2025

【英語タイトル】Global Antihemophilic Factor Drug Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

QYResearchが出版した調査資料(QYR8D00496)・商品コード:QYR8D00496
・発行会社(調査会社):QYResearch
・発行日:2018年11月14日(※2024年版があります。お問い合わせください)
・ページ数:117
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、世界主要国
・産業分野:製薬・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、抗血友病用薬の世界市場について調査・分析し、種類別には、250IU、500IU、1000IU、1500IU、2000IU、3000IU、4000IU、その他力価に、用途別には、大人、小児用に区分してまとめました。調査対象企業は、Bayer、Shire、Novo Nordisk、Pfizer、Grifols、CSL Behring、Sanofi、Cigna、Octapharma、GC Pharma、Hualan Biological Engineering、Shanghai RAAS blood products等です。

・レポートの概要
・グローバル成長トレンド
・抗血友病用薬の世界市場規模
・抗血友病用薬の地域別市場規模
・グローバル産業動向
・企業別市場シェア
・企業別抗血友病用薬の価格動向
・抗血友病用薬の種類別市場規模(250IU、500IU、1000IU、1500IU、2000IU、3000IU、4000IU、その他力価)
・抗血友病用薬の用途別市場規模(大人、小児用)
・抗血友病用薬の北米市場(アメリカ、カナダ、メキシコ)
・抗血友病用薬のヨーロッパ市場(ドイツ、フランス、イギリス、イタリア、ロシア)
・抗血友病用薬のアジア市場(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・抗血友病用薬の中南米市場(ブラジル等)
・抗血友病用薬の中東・アフリカ市場(GCC、エジプト、南アフリカ)
・主要企業情報(Bayer、Shire、Novo Nordisk、Pfizer、Grifols、CSL Behring、Sanofi、Cigna、Octapharma、GC Pharma、Hualan Biological Engineering、Shanghai RAAS blood products)
 -企業概要、事業概要、販売・売上・市場シェア、XXX製品概要、企業動向
・バリューチェーン及び販売チャネル分析
・抗血友病用薬の市場規模予測
・抗血友病用薬の種類別市場予測2018-2025(250IU、500IU、1000IU、1500IU、2000IU、3000IU、4000IU、その他力価)
・抗血友病用薬の用途別市場予測2018-2025(大人、小児用)
・抗血友病用薬の北米市場予測2018-2025(アメリカ、カナダ、メキシコ)
・抗血友病用薬のヨーロッパ市場予測2018-2025(ドイツ、フランス、イギリス、イタリア、ロシア)
・抗血友病用薬のアジア市場予測2018-2025(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・抗血友病用薬の中南米市場予測2018-2025(ブラジル等)
・抗血友病用薬の中東・アフリカ市場予測2018-2025(GCC、エジプト、南アフリカ)
・調査結果及び結論
【レポートの概要】

Antihemophilic Factor Drug is used to control and prevent bleeding episodes in people with low levels of factor VIII (hemophilia A). It is also used in these patients before surgery to prevent bleeding.In 2018, the global Antihemophilic Factor Drug market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Antihemophilic Factor Drug.

This study researches the market size of Antihemophilic Factor Drug, presents the global Antihemophilic Factor Drug sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
This report focuses on the key data information of Antihemophilic Factor Drug in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Antihemophilic Factor Drug for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Bayer
Shire
Novo Nordisk
Pfizer
Grifols
CSL Behring
Sanofi
Cigna
Octapharma
GC Pharma
Hualan Biological Engineering
Shanghai RAAS blood products

Market Segment by Product Type
250 IU
500 IU
1000 IU
1500 IU
2000 IU
3000 IU
4000 IU
Other potencies

Market Segment by Application
Adult
Pediatric

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Antihemophilic Factor Drug status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Antihemophilic Factor Drug manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Antihemophilic Factor Drug are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Antihemophilic Factor Drug Market Size Growth Rate by Type
1.3.2 250 IU
1.3.3 500 IU
1.3.4 1000 IU
1.3.5 1500 IU
1.3.6 2000 IU
1.3.7 3000 IU
1.3.8 4000 IU
1.3.9 Other potencies
1.4 Market Segment by Application
1.4.1 Global Antihemophilic Factor Drug Market Share by Application (2018-2025)
1.4.2 Adult
1.4.3 Pediatric
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Antihemophilic Factor Drug Market Size
2.1.1 Global Antihemophilic Factor Drug Revenue 2013-2025
2.1.2 Global Antihemophilic Factor Drug Sales 2013-2025
2.2 Antihemophilic Factor Drug Growth Rate by Regions
2.2.1 Global Antihemophilic Factor Drug Sales by Regions 2013-2018
2.2.2 Global Antihemophilic Factor Drug Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Antihemophilic Factor Drug Sales by Manufacturers
3.1.1 Antihemophilic Factor Drug Sales by Manufacturers 2013-2018
3.1.2 Antihemophilic Factor Drug Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Antihemophilic Factor Drug Revenue by Manufacturers (2013-2018)
3.2.2 Antihemophilic Factor Drug Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Antihemophilic Factor Drug Market Concentration Ratio (CR5 and HHI)
3.3 Antihemophilic Factor Drug Price by Manufacturers
3.4 Key Manufacturers Antihemophilic Factor Drug Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Antihemophilic Factor Drug Market
3.6 Key Manufacturers Antihemophilic Factor Drug Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 250 IU Sales and Revenue (2013-2018)
4.1.2 500 IU Sales and Revenue (2013-2018)
4.1.3 1000 IU Sales and Revenue (2013-2018)
4.1.4 1500 IU Sales and Revenue (2013-2018)
4.1.5 2000 IU Sales and Revenue (2013-2018)
4.1.6 3000 IU Sales and Revenue (2013-2018)
4.1.7 4000 IU Sales and Revenue (2013-2018)
4.1.8 Other potencies Sales and Revenue (2013-2018)
4.2 Global Antihemophilic Factor Drug Sales Market Share by Type
4.3 Global Antihemophilic Factor Drug Revenue Market Share by Type
4.4 Antihemophilic Factor Drug Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Antihemophilic Factor Drug Sales by Application

6 North America
6.1 North America Antihemophilic Factor Drug Breakdown Data by Company
6.2 North America Antihemophilic Factor Drug Breakdown Data by Type
6.3 North America Antihemophilic Factor Drug Breakdown Data by Application
6.4 North America Antihemophilic Factor Drug Breakdown Data by Countries
6.4.1 North America Antihemophilic Factor Drug Sales by Countries
6.4.2 North America Antihemophilic Factor Drug Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Antihemophilic Factor Drug Breakdown Data by Company
7.2 Europe Antihemophilic Factor Drug Breakdown Data by Type
7.3 Europe Antihemophilic Factor Drug Breakdown Data by Application
7.4 Europe Antihemophilic Factor Drug Breakdown Data by Countries
7.4.1 Europe Antihemophilic Factor Drug Sales by Countries
7.4.2 Europe Antihemophilic Factor Drug Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Antihemophilic Factor Drug Breakdown Data by Company
8.2 Asia Pacific Antihemophilic Factor Drug Breakdown Data by Type
8.3 Asia Pacific Antihemophilic Factor Drug Breakdown Data by Application
8.4 Asia Pacific Antihemophilic Factor Drug Breakdown Data by Countries
8.4.1 Asia Pacific Antihemophilic Factor Drug Sales by Countries
8.4.2 Asia Pacific Antihemophilic Factor Drug Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Antihemophilic Factor Drug Breakdown Data by Company
9.2 Central & South America Antihemophilic Factor Drug Breakdown Data by Type
9.3 Central & South America Antihemophilic Factor Drug Breakdown Data by Application
9.4 Central & South America Antihemophilic Factor Drug Breakdown Data by Countries
9.4.1 Central & South America Antihemophilic Factor Drug Sales by Countries
9.4.2 Central & South America Antihemophilic Factor Drug Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Antihemophilic Factor Drug Breakdown Data by Type
10.2 Middle East and Africa Antihemophilic Factor Drug Breakdown Data by Application
10.3 Middle East and Africa Antihemophilic Factor Drug Breakdown Data by Countries
10.3.1 Middle East and Africa Antihemophilic Factor Drug Sales by Countries
10.3.2 Middle East and Africa Antihemophilic Factor Drug Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa

11 Company Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Antihemophilic Factor Drug
11.1.4 Antihemophilic Factor Drug Product Introduction
11.1.5 Bayer Recent Development
11.2 Shire
11.2.1 Shire Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Antihemophilic Factor Drug
11.2.4 Antihemophilic Factor Drug Product Introduction
11.2.5 Shire Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Antihemophilic Factor Drug
11.3.4 Antihemophilic Factor Drug Product Introduction
11.3.5 Novo Nordisk Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Antihemophilic Factor Drug
11.4.4 Antihemophilic Factor Drug Product Introduction
11.4.5 Pfizer Recent Development
11.5 Grifols
11.5.1 Grifols Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Antihemophilic Factor Drug
11.5.4 Antihemophilic Factor Drug Product Introduction
11.5.5 Grifols Recent Development
11.6 CSL Behring
11.6.1 CSL Behring Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Antihemophilic Factor Drug
11.6.4 Antihemophilic Factor Drug Product Introduction
11.6.5 CSL Behring Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Antihemophilic Factor Drug
11.7.4 Antihemophilic Factor Drug Product Introduction
11.7.5 Sanofi Recent Development
11.8 Cigna
11.8.1 Cigna Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Antihemophilic Factor Drug
11.8.4 Antihemophilic Factor Drug Product Introduction
11.8.5 Cigna Recent Development
11.9 Octapharma
11.9.1 Octapharma Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Antihemophilic Factor Drug
11.9.4 Antihemophilic Factor Drug Product Introduction
11.9.5 Octapharma Recent Development
11.10 GC Pharma
11.10.1 GC Pharma Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Antihemophilic Factor Drug
11.10.4 Antihemophilic Factor Drug Product Introduction
11.10.5 GC Pharma Recent Development
11.11 Hualan Biological Engineering
11.12 Shanghai RAAS blood products

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Antihemophilic Factor Drug Sales Channels
12.2.2 Antihemophilic Factor Drug Distributors
12.3 Antihemophilic Factor Drug Customers

13 Market Forecast
13.1 Global Antihemophilic Factor Drug Sales and Revenue Forecast 2018-2025
13.2 Global Antihemophilic Factor Drug Sales Forecast by Type
13.3 Global Antihemophilic Factor Drug Sales Forecast by Application
13.4 Antihemophilic Factor Drug Forecast by Regions
13.4.1 Global Antihemophilic Factor Drug Sales Forecast by Regions 2018-2025
13.4.2 Global Antihemophilic Factor Drug Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Antihemophilic Factor Drug Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Antihemophilic Factor Drug Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Antihemophilic Factor Drug Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Antihemophilic Factor Drug Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Antihemophilic Factor Drug Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Antihemophilic Factor Drug Product Picture
Table Antihemophilic Factor Drug Key Market Segments
Table Major Manufacturers Antihemophilic Factor Drug Covered in This Report
Table Global Antihemophilic Factor Drug Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
Figure Global Antihemophilic Factor Drug Sales Market Shar by Type 2013-2025
Figure 250 IU Figures
Table Major Manufacturers of 250 IU
Figure 500 IU Figures
Table Major Manufacturers of 500 IU
Figure 1000 IU Figures
Table Major Manufacturers of 1000 IU
Figure 1500 IU Figures
Table Major Manufacturers of 1500 IU
Figure 2000 IU Figures
Table Major Manufacturers of 2000 IU
Figure 3000 IU Figures
Table Major Manufacturers of 3000 IU
Figure 4000 IU Figures
Table Major Manufacturers of 4000 IU
Figure Other potencies Figures
Table Major Manufacturers of Other potencies
Table Global Antihemophilic Factor Drug Market Share by Application 2018-2025 (K Units)
Figure Adult Use Case
Figure Pediatric Use Case
Figure Antihemophilic Factor Drug Report Years Considered
Figure Global Antihemophilic Factor Drug Market Size 2013-2025 (Million US$)
Figure Global Antihemophilic Factor Drug Sales 2013-2018 (K Units)
Table Global Antihemophilic Factor Drug Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Antihemophilic Factor Drug Sales by Regions 2013-2018 (K Units)
Table Global Antihemophilic Factor Drug Sales Market Share by Regions 2013-2018
Figure Global Antihemophilic Factor Drug Sales Market Share by Regions 2013-2018
Figure Global Antihemophilic Factor Drug Sales Market Share by Regions in 2018
Table Global Antihemophilic Factor Drug Revenue by Regions 2013-2018 (Million US$)
Table Global Antihemophilic Factor Drug Revenue Market Share by Regions 2013-2018
Figure Global Antihemophilic Factor Drug Revenue Market Share by Regions 2013-2018
Figure Global Antihemophilic Factor Drug Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Antihemophilic Factor Drug Sales by Manufacturers (2013-2018) (K Units)
Table Global Antihemophilic Factor Drug Sales Share by Manufacturers (2013-2018)
Figure Global Antihemophilic Factor Drug Sales Share by Manufacturers in 2018
Table Antihemophilic Factor Drug Revenue by Manufacturers (2013-2018) (Million USD)
Table Antihemophilic Factor Drug Revenue Share by Manufacturers (2013-2018)
Figure Antihemophilic Factor Drug Value Share by Manufacturers in 2018
Table Global Antihemophilic Factor Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Antihemophilic Factor Drug Price (2013-2018) (USD/Unit)
Table Key Manufacturers Antihemophilic Factor Drug Plants/Factories Distribution
Table Key Manufacturers Antihemophilic Factor Drug Area Served
Table Date of Key Manufacturers Enter into Antihemophilic Factor Drug Market
Table Key Manufacturers Antihemophilic Factor Drug Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global 250 IU Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global 500 IU Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global 1000 IU Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global 1500 IU Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global 2000 IU Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global 3000 IU Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global 4000 IU Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Other potencies Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Antihemophilic Factor Drug Sales by Type (2013-2018) (K Units)
Table Global Antihemophilic Factor Drug Sales Share by Type (2013-2018)
Figure Global Antihemophilic Factor Drug Sales Market Share by Type (2013-2018)
Figure Global Antihemophilic Factor Drug Sales Market Share by Type in 2017
Table Global Antihemophilic Factor Drug Revenue by Type (2013-2018) (Million US$)
Table Global Antihemophilic Factor Drug Revenue Share by Type (2013-2018)
Figure Global Antihemophilic Factor Drug Revenue Market Share by Type (2013-2018)
Figure Global Antihemophilic Factor Drug Revenue Market Share by Type in 2017
Table Antihemophilic Factor Drug Price by Type 2013-2018 (USD/Unit)
Table Global Antihemophilic Factor Drug Sales by Application (2013-2018) (K Units)
Table Global Antihemophilic Factor Drug Sales Share by Application (2013-2018)
Figure Global Sales Antihemophilic Factor Drug Market Share by Application (2013-2018)
Figure Global Sales Antihemophilic Factor Drug Market Share by Application in 2017
Figure North America Antihemophilic Factor Drug Sales Growth Rate 2013-2018 (K Units)
Figure North America Antihemophilic Factor Drug Revenue Growth Rate 2013-2018 (Million US$)
Table North America Antihemophilic Factor Drug Sales by Company (2013-2018) (K Units)
Table North America Antihemophilic Factor Drug Sales Market Share by Company (2013-2018)
Figure North America Antihemophilic Factor Drug Sales Market Share by Company in 2018
Table North America Antihemophilic Factor Drug Sales by Type (2013-2018) (K Units)
Table North America Antihemophilic Factor Drug Sales Market Share by Type (2013-2018)
Figure North America Antihemophilic Factor Drug Market Share by Type in 2018
Table North America Antihemophilic Factor Drug Sales by Application (2013-2018) (K Units)
Table North America Antihemophilic Factor Drug Sales Market Share by Application (2013-2018)
Figure North America Antihemophilic Factor Drug Market Share by Application in 2018
Table North America Antihemophilic Factor Drug Sales by Countries (2013-2018) (K Units)
Table North America Antihemophilic Factor Drug Sales Market Share by Countries (2013-2018)
Figure 2017 North America Antihemophilic Factor Drug Sales Market Share by Countries
Table North America Antihemophilic Factor Drug Revenue by Countries (2013-2018) (Million US$)
Table North America Antihemophilic Factor Drug Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Antihemophilic Factor Drug Revenue Market Share by Countries
Figure United States Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Canada Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Europe Antihemophilic Factor Drug Sales Growth Rate 2013-2018 (K Units)
Figure Europe Antihemophilic Factor Drug Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Antihemophilic Factor Drug Sales by Company (2013-2018) (K Units)
Table Europe Antihemophilic Factor Drug Sales Market Share by Company (2013-2018)
Figure Europe Antihemophilic Factor Drug Sales Market Share by Company in 2018
Table Europe Antihemophilic Factor Drug Sales by Type (2013-2018) (K Units)
Table Europe Antihemophilic Factor Drug Sales Market Share by Type (2013-2018)
Figure 2017 Europe Antihemophilic Factor Drug Market Share by Type
Table Europe Antihemophilic Factor Drug Sales by Application (2013-2018) (K Units)
Table Europe Antihemophilic Factor Drug Sales Market Share by Application (2013-2018)
Figure 2017 Europe Antihemophilic Factor Drug Market Share by Application
Table Europe Antihemophilic Factor Drug Sales by Countries (2013-2018) (K Units)
Table Europe Antihemophilic Factor Drug Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Antihemophilic Factor Drug Sales Market Share by Countries
Table Europe Antihemophilic Factor Drug Revenue by Countries (2013-2018) (Million US$)
Table Europe Antihemophilic Factor Drug Revenue Market Share by Countries (2013-2018)
Figure Europe Antihemophilic Factor Drug Revenue Market Share by Countries in 2018
Figure Germany Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure France Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure UK Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Italy Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Russia Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Asia Pacific Antihemophilic Factor Drug Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Antihemophilic Factor Drug Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Antihemophilic Factor Drug Sales by Company (2013-2018) (K Units)
Table Asia Pacific Antihemophilic Factor Drug Sales Market Share by Company (2013-2018)
Figure Asia Pacific Antihemophilic Factor Drug Sales Market Share by Company in 2018
Table Asia Pacific Antihemophilic Factor Drug Sales by Type (2013-2018) (K Units)
Table Asia Pacific Antihemophilic Factor Drug Sales Market Share by Type (2013-2018)
Figure Asia Pacific Antihemophilic Factor Drug Market Share by Type in 2018
Table Asia Pacific Antihemophilic Factor Drug Sales by Application (2013-2018) (K Units)
Table Asia Pacific Antihemophilic Factor Drug Sales Market Share by Application (2013-2018)
Figure Asia Pacific Antihemophilic Factor Drug Market Share by Application in 2018
Table Asia Pacific Antihemophilic Factor Drug Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Antihemophilic Factor Drug Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Antihemophilic Factor Drug Sales Market Share by Countries
Table Asia Pacific Antihemophilic Factor Drug Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Antihemophilic Factor Drug Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Antihemophilic Factor Drug Revenue Market Share by Countries
Figure China Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure China Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Japan Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Korea Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (Million US$)
Figure India Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure India Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Australia Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (Million US$)
Figure Central & South America Antihemophilic Factor Drug Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Antihemophilic Factor Drug Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Antihemophilic Factor Drug Sales by Company (2013-2018) (K Units)
Table Central & South America Antihemophilic Factor Drug Sales Market Share by Company (2013-2018)
Figure Central & South America Antihemophilic Factor Drug Sales Market Share by Company in 2018
Table Central & South America Antihemophilic Factor Drug Sales by Type (2013-2018) (K Units)
Table Central & South America Antihemophilic Factor Drug Sales Market Share by Type (2013-2018)
Figure Central & South America Antihemophilic Factor Drug Market Share by Type in 2018
Table Central & South America Antihemophilic Factor Drug Sales by Application (2013-2018) (K Units)
Table Central & South America Antihemophilic Factor Drug Sales Market Share by Application (2013-2018)
Figure Central & South America Antihemophilic Factor Drug Market Share by Application in 2018
Table Central & South America Antihemophilic Factor Drug Sales by Countries (2013-2018) (K Units)
Table Central & South America Antihemophilic Factor Drug Sales Market Share by Countries (2013-2018)
Figure Central & South America Antihemophilic Factor Drug Sales Market Share by Countries in 2018
Table Central & South America Antihemophilic Factor Drug Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Antihemophilic Factor Drug Revenue Market Share by Countries (2013-2018)
Figure Central & South America Antihemophilic Factor Drug Revenue Market Share by Countries in 2018
Figure Brazil Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (K Units)
Figure Middle East and Africa Antihemophilic Factor Drug Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Antihemophilic Factor Drug Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Antihemophilic Factor Drug Sales by Type (2013-2018) (K Units)
Table Middle East and Africa Antihemophilic Factor Drug Sales Market Share by Type (2013-2018)
Figure 2017 Middle East and Africa Antihemophilic Factor Drug Market Share by Type
Table Middle East and Africa Antihemophilic Factor Drug Sales by Application (2013-2018) (K Units)
Table Middle East and Africa Antihemophilic Factor Drug Sales Market Share by Application (2013-2018)
Figure 2017 Middle East and Africa Antihemophilic Factor Drug Market Share by Application
Table Middle East and Africa Antihemophilic Factor Drug Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Antihemophilic Factor Drug Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Antihemophilic Factor Drug Sales Market Share by Countries
Table Middle East and Africa Antihemophilic Factor Drug Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Antihemophilic Factor Drug Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Antihemophilic Factor Drug Revenue Market Share by Countries
Figure GCC Countries Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (K Units)
Figure Egypt Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (K Units)
Figure South Africa Antihemophilic Factor Drug Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Antihemophilic Factor Drug Revenue Growth Rate (2013-2018) (K Units)
Table Bayer Company Details
Table Bayer Description and Business Overview
Table Bayer Antihemophilic Factor Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Bayer Antihemophilic Factor Drug Sales Growth Rate (2013-2018)
Table Bayer Antihemophilic Factor Drug Sales Market Share in Global Market
Table Bayer Recent Development
Table Shire Company Details
Table Shire Description and Business Overview
Table Shire Antihemophilic Factor Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Shire Antihemophilic Factor Drug Sales Growth Rate (2013-2018)
Table Shire Antihemophilic Factor Drug Sales Market Share in Global Market
Table Shire Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Description and Business Overview
Table Novo Nordisk Antihemophilic Factor Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Novo Nordisk Antihemophilic Factor Drug Sales Growth Rate (2013-2018)
Table Novo Nordisk Antihemophilic Factor Drug Sales Market Share in Global Market
Table Novo Nordisk Recent Development
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Antihemophilic Factor Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Pfizer Antihemophilic Factor Drug Sales Growth Rate (2013-2018)
Table Pfizer Antihemophilic Factor Drug Sales Market Share in Global Market
Table Pfizer Recent Development
Table Grifols Company Details
Table Grifols Description and Business Overview
Table Grifols Antihemophilic Factor Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Grifols Antihemophilic Factor Drug Sales Growth Rate (2013-2018)
Table Grifols Antihemophilic Factor Drug Sales Market Share in Global Market
Table Grifols Recent Development
Table CSL Behring Company Details
Table CSL Behring Description and Business Overview
Table CSL Behring Antihemophilic Factor Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table CSL Behring Antihemophilic Factor Drug Sales Growth Rate (2013-2018)
Table CSL Behring Antihemophilic Factor Drug Sales Market Share in Global Market
Table CSL Behring Recent Development
Table Sanofi Company Details
Table Sanofi Description and Business Overview
Table Sanofi Antihemophilic Factor Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Sanofi Antihemophilic Factor Drug Sales Growth Rate (2013-2018)
Table Sanofi Antihemophilic Factor Drug Sales Market Share in Global Market
Table Sanofi Recent Development
Table Cigna Company Details
Table Cigna Description and Business Overview
Table Cigna Antihemophilic Factor Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Cigna Antihemophilic Factor Drug Sales Growth Rate (2013-2018)
Table Cigna Antihemophilic Factor Drug Sales Market Share in Global Market
Table Cigna Recent Development
Table Octapharma Company Details
Table Octapharma Description and Business Overview
Table Octapharma Antihemophilic Factor Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Octapharma Antihemophilic Factor Drug Sales Growth Rate (2013-2018)
Table Octapharma Antihemophilic Factor Drug Sales Market Share in Global Market
Table Octapharma Recent Development
Table GC Pharma Company Details
Table GC Pharma Description and Business Overview
Table GC Pharma Antihemophilic Factor Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table GC Pharma Antihemophilic Factor Drug Sales Growth Rate (2013-2018)
Table GC Pharma Antihemophilic Factor Drug Sales Market Share in Global Market
Table GC Pharma Recent Development
Table Hualan Biological Engineering Company Details
Table Shanghai RAAS blood products Company Details
Figure Antihemophilic Factor Drug Value Chain
Table Antihemophilic Factor Drug Distributors List
Table Antihemophilic Factor Drug Customers List
Table Global Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units) & (Million US$)
Figure Global Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure Global Antihemophilic Factor Drug Revenue Forecast 2018-2025 (Million US$)
Table Global Antihemophilic Factor Drug Sales Forecast by Type 2018-2025 (K Units)
Figure Global Antihemophilic Factor Drug Sales Forecast by Type 2018-2025 (K Units)
Figure Global Antihemophilic Factor Drug Sales Market Share Forecast by Type 2018-2025
Table Global Antihemophilic Factor Drug Sales Forecast by Application 2018-2025 (K Units)
Figure Global Antihemophilic Factor Drug Sales Forecast by Application 2018-2025 (K Units)
Figure Global Antihemophilic Factor Drug Sales Market Share Forecast by Application 2018-2025
Table Global Antihemophilic Factor Drug Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Antihemophilic Factor Drug Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Antihemophilic Factor Drug Sales Market Share Forecast by Regions 2018-2025
Table Global Antihemophilic Factor Drug Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Antihemophilic Factor Drug Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Antihemophilic Factor Drug Revenue Market Share Forecast by Regions 2018-2025
Table North America Antihemophilic Factor Drug Sales Forecast by Countries 2018-2025 (K Units)
Table North America Antihemophilic Factor Drug Sales Market Share Forecast by Countries 2018-2025
Table North America Antihemophilic Factor Drug Revenue Forecast by Countries 2018-2025 (Million US$)
Table North America Antihemophilic Factor Drug Revenue Market Share Forecast by Countries 2018-2025
Figure United States Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure Canada Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure MexicoAntihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Table Europe Antihemophilic Factor Drug Sales Forecast by Countries 2018-2025 (K Units)
Table Europe Antihemophilic Factor Drug Sales Market Share Forecast by Countries 2018-2025
Table Europe Antihemophilic Factor Drug Revenue Forecast by Countries 2018-2025 (Million US$)
Table Europe Antihemophilic Factor Drug Revenue Market Share Forecast by Countries 2018-2025
Figure Germany Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure France Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure UK Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure Italy Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure Russia Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Table Asia Pacific Antihemophilic Factor Drug Sales Forecast by Countries 2018-2025 (K Units)
Table Asia Pacific Antihemophilic Factor Drug Sales Market Share Forecast by Countries 2018-2025
Table Asia Pacific Antihemophilic Factor Drug Revenue Forecast by Countries 2018-2025 (Million US$)
Table Asia Pacific Antihemophilic Factor Drug Revenue Market Share Forecast by Countries 2018-2025
Figure China Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure Japan Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure Korea Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure India Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure Australia Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure Indonesia Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure Thailand Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure Malaysia Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure Philippines Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Figure Vietnam Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Table Central & South America Antihemophilic Factor Drug Sales Forecast by Countries 2018-2025 (K Units)
Table Central & South America Antihemophilic Factor Drug Sales Market Share Forecast by Countries 2018-2025
Table Central & South America Antihemophilic Factor Drug Revenue Forecast by Countries 2018-2025 (Million US$)
Table Central & South America Antihemophilic Factor Drug Revenue Market Share Forecast by Countries 2018-2025
Figure Brazil Antihemophilic Factor Drug Sales Forecast 2018-2025 (K Units)
Table Middle East and Africa Antihemophilic Factor Drug Sales Forecast by Regions 2018-2025 (K Units)
Table Middle East and Africa Antihemophilic Factor Drug Sales Market Share Forecast by Regions 2018-2025
Table Middle East and Africa Antihemophilic Factor Drug Revenue Forecast by Regions 2018-2025 (Million US$)
Table Middle East and Africa Antihemophilic Factor Drug Revenue Market Share Forecast by Regions 2018-2025
Figure GCC Countries Antihemophilic Factor Drug Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Antihemophilic Factor Drug Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Antihemophilic Factor Drug Sales Growth Rate (2016-2025) (K Units)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Bayer、Shire、Novo Nordisk、Pfizer、Grifols、CSL Behring、Sanofi、Cigna、Octapharma、GC Pharma、Hualan Biological Engineering、Shanghai RAAS blood products

★調査レポート[抗血友病用薬の世界市場動向・分析2018-2025] (コード:QYR8D00496)販売に関する免責事項を必ずご確認ください。
★調査レポート[抗血友病用薬の世界市場動向・分析2018-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆